Nov 18, 2024 / 10:30AM GMT
Operator
Ladies and gentlemen, good day, and welcome to the Q2 and FY25 earnings conference call of Gufic Biosciences Limited. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Ms. Ami Shah, Company Secretary. Thank you, and over to you, ma'am.
Ami Shah - Gufic Biosciences Ltd - Compliance Officer, Company Secretary
Thank you, Sejal. Good evening, everyone. I welcome you all to Gufic Biosciences Limited Earnings Conference Call for the Second Quarter of Financial Year '24-'25. We have with us today Mr. Pranav Choksi, CEO and Director; Mr. Devkinandan Roonghta, CFO; and Mr. Avik Das from Investor Relations team. To give the highlights of the business and financial performance of the company and to take questions, if any.
Before we begin, I would like to state that some of the statements that will be made in today's discussion may be forward-looking in nature. It is subject to unfortunate risks and uncertainties, and the actual results could materially differ. The company undertakes no
Q2 2025 Gufic Biosciences Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot